Clover Health Investments, Corp. (CLOV) Stock Score, Valuation & Financial Research
Clover Health Investments, Corp. is in the Healthcare sector and Medical - Healthcare Plans industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 34/100.
Quick answer for CLOV
Clover Health Investments, Corp. currently has a Wall Street Score of 34/100. The stored market price is $5.09. Its financial score is 50/100. Its valuation score is 0/100. The latest WSS change is -0.5 points. These figures are a research snapshot, not a buy or sell recommendation.
What Clover Health Investments, Corp. does
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
CLOV financial snapshot
- Wall Street Score:
- 34/100
- Current price:
- $5.09
- Market capitalization:
- $2.64B
- Revenue:
- $2.48B
- Net income:
- $-18.4M
- Free cash flow:
- $-69.0M
- Cash:
- $198.8M
- Total debt:
- $0
- EPS:
- -0.04
- Financial score:
- 50/100
- Valuation score:
- 0/100
- Revenue score:
- 48/100
What stands out
- Reported year-over-year revenue growth is +0.3%.
- Free cash flow is $-69.0M, showing cash burn in the current stored period.
- The balance sheet shows $198.8M of cash versus $0 of total debt, leaving more cash than debt.
- The latest Wall Street Score change is -0.5 points: CLOV decreased 0.5 points because Capital declined by 2 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 50/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-14.
How to research CLOV
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.